| Mrs Jennifer Whaley, CRNA | |
|
1638 Owen Dr, Fayetteville, NC 28304-3424 | |
| (910) 485-6000 | |
| Not Available |
| Full Name | Mrs Jennifer Whaley |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 1638 Owen Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215487087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 201446 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeastern Regional Medical Center | Lumberton, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cumberland County Hospital System Inc | 1850204041 | 455 |
| Medstream Anesthesia Pllc | 7416198049 | 566 |
| Brunswick Community Hospital Llc | 9335150895 | 31 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Thomasville Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033160205 PECOS PAC ID: 5890605224 Enrollment ID: O20031222000916 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Medical Park Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003867516 PECOS PAC ID: 4880595958 Enrollment ID: O20040120000968 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Forsyth Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104548874 PECOS PAC ID: 9537071790 Enrollment ID: O20040405001702 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Matthews Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Ballantyne Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215061049 PECOS PAC ID: 4587759949 Enrollment ID: O20070928000739 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Bladen Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558537282 PECOS PAC ID: 6800967969 Enrollment ID: O20080617000314 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Huntersville Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1063641801 PECOS PAC ID: 8426197971 Enrollment ID: O20100521000450 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Brunswick Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669725198 PECOS PAC ID: 9335150895 Enrollment ID: O20130903000403 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140304001209 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Johnston Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275735425 PECOS PAC ID: 2163655283 Enrollment ID: O20140612002236 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Kernersville Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1750892659 PECOS PAC ID: 3870858525 Enrollment ID: O20180530000007 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Mint Hill Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063910404 PECOS PAC ID: 8123374394 Enrollment ID: O20181018000540 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Entity Name | Novant Health Clemmons Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1528521887 PECOS PAC ID: 6103154778 Enrollment ID: O20190820003091 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Whaley, CRNA 127 Rowland Cir, Fayetteville, NC 28301-3835 Ph: (910) 229-8309 | Mrs Jennifer Whaley, CRNA 1638 Owen Dr, Fayetteville, NC 28304-3424 Ph: (910) 485-6000 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
A new study has shown that the risk of Alzheimer's disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
› Verified 4 days ago
Mrs. Leesa Davis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 | |
Mrs. Miriah Catherine Adams, RN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5132 | |
Dr. Jonathan Ray Hall, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2053 Valleygate Dr Ste 102, Fayetteville, NC 28304 Phone: 910-323-3757 | |
Edelrose Fortea Bacanto, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 805-509-7556 | |
Miss Jennifer Shattuck, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 | |
Jennifer Myles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5132 Fax: 910-321-6236 | |
Mrs. Debbie Morales, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 |